Citi raised the firm’s price target on Establishment Labs to $49 from $32 and keeps a Buy rating on the shares post the Q4 report. While the company’s second half of 2023 results reflect a slower market, management once again reiterated that it is seeing stabilization, expecting improvement throughout 2024, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ESTA:
- Establishment Labs reports Q4 EPS (79c), consensus (91c)
- Is ESTA a Buy, Before Earnings?
- Establishment Labs Amends Credit Terms with Oaktree Fund
- Establishment Labs Announces Potential 2M Share Sale
- Establishment Labs launches Motiva Implants in China
Questions or Comments about the article? Write to editor@tipranks.com